EVIO, Inc. (EVIO)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
EVIO, Inc. (EVIO) with AI Score 47/100 (Weak). EVIO, Inc. provides analytical testing and advisory services to the cannabis industry in the United States. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 17, 2026EVIO, Inc. (EVIO) Healthcare & Pipeline Overview
EVIO, Inc. provides analytical testing and advisory services to the U.S. cannabis industry, offering consulting, product formulation, and comprehensive testing services. With a focus on cannabinoid potency, pesticide screening, and regulatory compliance, EVIO supports cannabis businesses in navigating the complex landscape of the evolving market.
Investment Thesis
EVIO, Inc. presents a focused play on the cannabis testing and advisory services market. With a P/E ratio of 3.34 and a gross margin of 33.0%, the company demonstrates potential profitability. Growth catalysts include the expansion of cannabis legalization across states, driving demand for testing and compliance services. Key risks include intense competition and the evolving regulatory landscape. Investors should monitor revenue growth, profitability improvements, and the company's ability to adapt to changing regulations in the cannabis industry. The company's beta of 81.01 indicates high volatility.
Based on FMP financials and quantitative analysis
Key Highlights
- EVIO, Inc. operates in the cannabis analytical testing and advisory services market within the United States.
- The company's profit margin is 3.0%, indicating a potential for improvement in operational efficiency.
- EVIO's gross margin stands at 33.0%, reflecting its ability to manage the cost of services effectively.
- The company's P/E ratio is 3.34, suggesting it may be undervalued compared to its earnings.
- EVIO's beta is 81.01, indicating high volatility compared to the market.
Competitors & Peers
Strengths
- Comprehensive suite of testing and advisory services.
- Expertise in cannabis testing and compliance.
- Established relationships with cannabis businesses.
- Reputation for accuracy and reliability.
Weaknesses
- Small size and limited resources.
- Dependence on the cannabis industry.
- Limited geographic reach.
- High beta indicating high volatility.
Catalysts
- Upcoming: Expansion into new states legalizing cannabis, increasing demand for testing services.
- Ongoing: Increasing regulatory scrutiny in the cannabis industry, driving demand for compliance services.
- Ongoing: Strategic partnerships with cannabis cultivators, processors, and retailers.
Risks
- Potential: Intense competition from other testing labs and consulting firms.
- Potential: Evolving regulatory landscape and potential changes in cannabis laws.
- Potential: Economic downturn affecting the cannabis industry.
- Ongoing: Limited financial disclosure due to OTC listing.
- Ongoing: Low trading volume and liquidity on the OTC market.
Growth Opportunities
- Expansion into New Geographies: As more states legalize cannabis, EVIO has the opportunity to expand its testing and advisory services into these new markets. This geographic expansion can significantly increase its revenue base. The timeline for this growth is dependent on the pace of legalization in different states, but it represents a substantial long-term growth opportunity. By establishing testing facilities and building relationships with local cannabis businesses, EVIO can capitalize on the growing demand for its services.
- Development of New Testing Services: EVIO can expand its service offerings to include more specialized testing services, such as heavy metal analysis or genetic testing of cannabis strains. These new services can attract a wider range of customers and increase revenue per client. The timeline for developing these services depends on the availability of technology and expertise, but it represents a valuable opportunity to differentiate EVIO from its competitors. This diversification can enhance EVIO's competitive advantage and market position.
- Strategic Partnerships: Forming strategic partnerships with cannabis cultivators, processors, and retailers can provide EVIO with a steady stream of clients and revenue. These partnerships can also help EVIO expand its geographic reach and service offerings. The timeline for establishing these partnerships depends on the company's ability to build relationships and negotiate favorable terms. However, these partnerships can provide a significant boost to EVIO's growth and profitability.
- Increased Regulatory Scrutiny: As the cannabis industry matures, regulatory scrutiny is likely to increase, driving demand for EVIO's compliance and testing services. This trend presents a significant growth opportunity for the company. The timeline for this growth is dependent on the actions of regulatory bodies, but it is likely to be a long-term trend. By staying ahead of the curve and offering comprehensive compliance solutions, EVIO can position itself as a trusted partner for cannabis businesses.
- Product Formulation and Advisory Services: EVIO can leverage its expertise in cannabis testing to offer product formulation and advisory services to cannabis businesses. This can help these businesses develop new and innovative products that meet regulatory requirements and consumer demand. The timeline for this growth depends on the company's ability to attract and retain talented scientists and consultants, but it represents a valuable opportunity to expand its service offerings and increase revenue.
Opportunities
- Expansion into new geographic markets.
- Development of new testing services.
- Strategic partnerships with cannabis businesses.
- Increased regulatory scrutiny driving demand for compliance services.
Threats
- Intense competition from other testing labs and consulting firms.
- Evolving regulatory landscape.
- Potential for changes in cannabis laws.
- Economic downturn affecting the cannabis industry.
Competitive Advantages
- Specialized expertise in cannabis testing and compliance.
- Established relationships with cannabis businesses.
- Comprehensive suite of testing and advisory services.
- Reputation for accuracy and reliability.
About EVIO
EVIO, Inc. was established to provide analytical testing and advisory services to businesses operating within the burgeoning cannabis industry in the United States. Recognizing the need for standardized testing and regulatory compliance in this rapidly evolving market, EVIO has positioned itself as a key service provider for cannabis cultivators, processors, and retailers. The company offers a comprehensive suite of services, including consulting, product formulation, and licensing and compliance assistance. Its analytical testing services encompass cannabinoid potency testing, terpene analysis, pesticide testing, residual solvent screening, visual inspections, and biological contaminant testing. These services are designed to ensure product safety, quality, and compliance with state and local regulations. Headquartered in Henderson, Nevada, EVIO, Inc. aims to support the growth and legitimacy of the cannabis industry by providing reliable and accurate testing and advisory solutions.
What They Do
- Provides analytical testing services to the cannabis industry.
- Offers consulting services related to cannabis product formulation.
- Assists cannabis businesses with licensing and compliance.
- Conducts cannabinoid potency testing.
- Performs terpene analysis.
- Screens for pesticides and residual solvents.
- Conducts visual inspections of cannabis products.
- Tests for biological contaminants.
Business Model
- Generates revenue through analytical testing services for cannabis products.
- Earns fees from consulting services related to product formulation and regulatory compliance.
- Partnerships with cannabis cultivators, processors, and retailers.
- Offers specialized testing services, such as heavy metal analysis and genetic testing.
Industry Context
EVIO, Inc. operates within the rapidly expanding cannabis industry, which is experiencing significant growth due to increasing legalization and acceptance across the United States. The market for cannabis testing and advisory services is becoming increasingly important as regulations tighten and consumers demand safer, more reliable products. Competition is intensifying, with numerous testing labs and consulting firms vying for market share. EVIO's success depends on its ability to maintain high standards of accuracy, compliance, and customer service in this dynamic environment.
Key Customers
- Cannabis cultivators
- Cannabis processors
- Cannabis retailers
- Cannabis product manufacturers
Financials
Chart & Info
EVIO, Inc. (EVIO) stock price: Price data unavailable
Latest News
-
Stocks That Hit 52-Week Lows On Friday
· Dec 6, 2019
-
Stocks That Hit 52-Week Lows On Thursday
· Dec 5, 2019
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for EVIO.
Price Targets
Wall Street price target analysis for EVIO.
MoonshotScore
What does this score mean?
The MoonshotScore rates EVIO's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Competitors & Peers
Leadership: Lori Jean Glauser
CEO
Lori Jean Glauser serves as the CEO of EVIO, Inc. Her background includes experience in managing and growing businesses, with a focus on strategic planning and execution. She has demonstrated leadership in navigating complex regulatory environments and building strong teams. Her expertise is crucial for guiding EVIO through the evolving cannabis industry landscape. She is responsible for overseeing all aspects of the company's operations and driving its growth strategy.
Track Record: Under Lori Jean Glauser's leadership, EVIO, Inc. has focused on expanding its testing and advisory services to meet the growing demand in the cannabis industry. She has overseen the development of new testing capabilities and the expansion of the company's geographic reach. Her strategic decisions have aimed to position EVIO as a trusted partner for cannabis businesses seeking to ensure product safety and regulatory compliance. She manages 18 employees.
EVIO OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that EVIO, Inc. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited financial information available to the public, and trading activity may be sporadic. Investing in companies on the OTC Other tier carries significant risks due to the lack of transparency and regulatory oversight compared to exchanges like the NYSE or NASDAQ.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure
- Low trading volume and liquidity
- Higher price volatility
- Potential for fraud or manipulation
- Lack of regulatory oversight
- Verify the company's financial statements.
- Research the company's management team and their track record.
- Assess the company's competitive position in the cannabis testing market.
- Review the company's regulatory filings and compliance history.
- Evaluate the company's growth prospects and expansion plans.
- Monitor trading volume and price volatility.
- Consult with a qualified financial advisor.
- Operational testing facilities and advisory services.
- Partnerships with established cannabis businesses.
- Compliance with state and local regulations.
- Positive customer reviews and testimonials.
- Experienced management team.
What Investors Ask About EVIO, Inc. (EVIO)
What does EVIO, Inc. do?
EVIO, Inc. provides analytical testing and advisory services to businesses operating in the cannabis industry. The company offers a range of services, including cannabinoid potency testing, terpene analysis, pesticide screening, and residual solvent testing. Additionally, EVIO provides consulting services related to product formulation, licensing, and regulatory compliance. By ensuring product safety and regulatory adherence, EVIO supports the growth and legitimacy of the cannabis market.
What do analysts say about EVIO stock?
As of 2026-03-17, formal analyst ratings for EVIO are limited, likely due to its OTC listing and smaller market capitalization. Key valuation metrics include a P/E ratio of 3.34 and a gross margin of 33.0%. Growth considerations revolve around the expansion of cannabis legalization and the increasing demand for testing and compliance services. Investors should conduct their own due diligence and consider the risks associated with investing in OTC stocks.
What are the main risks for EVIO?
The main risks for EVIO include intense competition in the cannabis testing market, the evolving regulatory landscape, and potential changes in cannabis laws. The company's OTC listing also presents risks related to limited financial disclosure, low trading volume, and higher price volatility. Additionally, an economic downturn could negatively impact the cannabis industry and reduce demand for EVIO's services. Investors should carefully consider these risks before investing in EVIO.
What are the key factors to evaluate for EVIO?
EVIO, Inc. (EVIO) currently holds an AI score of 47/100, indicating low score. Key strength: Comprehensive suite of testing and advisory services.. Primary risk to monitor: Potential: Intense competition from other testing labs and consulting firms.. This is not financial advice.
How frequently does EVIO data refresh on this page?
EVIO prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven EVIO's recent stock price performance?
Recent price movement in EVIO, Inc. (EVIO) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Comprehensive suite of testing and advisory services.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider EVIO overvalued or undervalued right now?
Determining whether EVIO, Inc. (EVIO) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying EVIO?
Before investing in EVIO, Inc. (EVIO), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available due to OTC listing.
- AI analysis pending for EVIO.